Advance in Slowing Prostate Cancer Made in Clinical Trials

By Health Day – Re-Blogged From Newsmax Health

Cutting-edge prostate cancer drugs that help extend life in the toughest cases might also be useful in fighting less aggressive tumors, two new clinical trials suggest.

Two drugs that interfere with cancer’s ability to use testosterone for fuel, apalutamide (Erleada) and enzalutamide (Xtandi), are already approved for use against more advanced prostate tumors that do not respond to regular therapy.

But these trials show the drugs also can improve survival and slow progression in prostate cancers that do respond to regular therapy, which typically involves medication that halts production of testosterone.

New Blood Test Reveals the Precise Time of Your Body’s Internal Clock

By Glenn McDonald – Re-Blogged From Seeker